# Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI)

> **NCT01502631** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 65 (actual)

## Conditions studied

- Acute Spinal Cord Injury

## Interventions

- **DRUG:** SUN13837 injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01502631
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08-08
- **Primary completion:** 2014-09-21
- **Final completion:** 2014-09-21
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2021-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01502631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01502631, "Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01502631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*